Search for: "In Re J. B" Results 61 - 80 of 4,240
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Apr 2024, 6:00 am by Lawrence Solum
 Persuasion by reasons operates through what Jürgen Habermas felicitously describes as the "unforced force of the better argument. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
8 Apr 2024, 10:08 am by admin
As a practical matter, the burden shifts to the party that wishes to challenge the relied upon facts and data to learn more about the cited studies to show that the facts and data are not sufficient under Rule 702(b), and that the testimony is not the product of reliable methods under Rule 702(c). [read post]
3 Apr 2024, 9:33 pm by Administrator
Ce principe d’égalité, caractéristique fondamentale des sociétés démocratiques, est déjà garanti par notre droit et notamment par l’art. 15 de la Charte canadienne (en ce qui concerne l’État) ainsi que par l’art. 10 de la Charte québécoise (ce dernier garantit l’exercice en toute égalité des droits reconnus par cette charte et vise… [read post]
3 Apr 2024, 9:05 pm by renholding
Dombalagian (who did not participate in In re Apple Securities Litigation), the John B. [read post]
3 Apr 2024, 4:08 pm by admin
Re-analyses can be important, but these reanalyses of published Bendectin studies were post hoc, litigation driven, and obviously result oriented. [read post]
2 Apr 2024, 4:50 am by Annsley Merelle Ward
b) Does the approach to a claim to a single chemical compound differ from a class? [read post]
27 Mar 2024, 3:39 pm by Guest Author
CFPB, Justice Kagan accused the majority of deploying an “anti-power-concentration principle” to declare the agency’s single-director structure unconstitutional.[2] She then quipped, without citation, that “[i]f you’ve never heard of a statute being struck down on that ground, you’re not alone. [read post]
25 Mar 2024, 1:15 pm by Guest Author
If you can’t set aside the rule and you’re not a regulated party, how is their injury redressable in this suit and why do they have standing? [read post]
19 Mar 2024, 10:13 am by Wiggam Law
Note that certain small employers that offer healthcare to their employees may need to file 1094-B and 1095-B. [read post]
12 Mar 2024, 12:46 pm by admin
., 45 F.2d 119, 123 (2d Cir. 1930) (Hand, J.). [2] In re Trasylol Prods. [read post]
11 Mar 2024, 6:55 am by Trane Robinson
  Compare In re MCP No. 165, 21 F.4th 357 (6th Cir. 2021) (Stranch, J., for the court), and id. at 388 (Gibbons, J., concurring), with id. at 389 (Larsen, J., dissenting), and In re MCP No. 165, 20 F.4th at 267 (Sutton, C.J., dissenting from denial of initial hearing en banc), and id. at 285 (Bush, J., dissenting). [read post]
8 Mar 2024, 12:30 pm by John Ross
Dissent (Elrod, J.): Venue is property where any substantial part of the events took place, not just the most substantial part. [read post]